Page 699 - Basic _ Clinical Pharmacology ( PDFDrive )

CHAPTER 37 Hypothalamic & Pituitary Hormones 685

PREP AR A TIONS A V AIL ABLE

GENERIC NAME AVAILABLE AS GENERIC NAME AVAILABLE AS
GROWTH FACTOR AGONISTS & ANTAGONISTS Leuprolide acetate Generic, Eligard, Lupron
Lanreotide acetate Somatuline Depot Lutropin alfa (rLH) Luveris *
Mecasermin Increlex Menotropins (hMG) Menopur, Repronex
Octreotide acetate Generic, Sandostatin, Sandostatin LAR Nafarelin acetate Synarel
Depot Triptorelin pamoate Trelstar, Trelstar LA, Trelstar Depot
Pegvisomant Somavert Urofollitropin Bravelle , Fertinex *
*
Somatropin Genotropin, Humatrope, Norditropin, PROLACTIN ANTAGONISTS (DOPAMINE AGONISTS)
Nutropin, Omnitrope, Saizen,
Serostim, Tev-tropin, Zorbtive Bromocriptine mesylate Generic, Parlodel, Cycloset
GONADOTROPIN AGONISTS & ANTAGONISTS Cabergoline Generic, Dostinex
Abarelix Plenaxis* OXYTOCIN
Cetrorelix acetate Cetrotide Oxytocin Generic, Pitocin
Choriogonadotropin alfa Ovidrel VASOPRESSIN AGONISTS AND ANTAGONISTS
(rhCG) Conivaptan HCl Vaprisol
Chorionic gonadotropin (hCG) Generic, Profasi, Pregnyl Desmopressin acetate Generic, Minirin, Stimate
Degarelix Firmagon (DDAVP)
Follitropin alfa (rFSH) Gonal-f Tolvaptan Samsca
Follitropin beta (rFSH) Follistim Vasopressin Generic, Pitressin
Ganirelix acetate Antagon OTHER
Gonadorelin hydrochloride Factrel Corticorelin ovine triflutate Acthrel
(GnRH) Corticotropin H.P. Acthar Gel
Goserelin acetate Zoladex Cosyntropin Generic, Cortrosyn, Cosyntropin
Histrelin acetate Supprelin LA, Vantas Thyrotropin alfa Thyrogen
* Withdrawn from the USA.

REFERENCES Katznelson L et al: American Association of Clinical Endocrinologists medical guide-
Abramovici A, Cantu J, Jenkins SM: Tocolytic therapy for acute preterm labor. lines for clinical practice for the diagnosis and treatment of acromegaly—2011
update. Endo Pract 2011;s4:1.
Obstet Gynecol Clin North Am 2012;39:77. Lanning NJ, Carter-Su C: Recent advances in growth hormone signaling. Rev
Al-Inany HG et al: Gonadotrophin-releasing hormone antagonists for assisted Endocr Metab Disord 2006;7:225.
reproductive technology. Cochrane Database Syst Rev 2011;(5):CD001750. Melmed S et al (editors): Williams Textbook of Endocrinology, 13th ed. Elsevier,
Beall SA, DeCherney A: History and challenges surrounding ovarian stimulation 2016.
in the treatment of infertility. Fertil Steril 2012;97:795. Papatsonis DN et al: Maintenance therapy with oxytocin antagonists for inhibiting
Caldwell PH, Deshpande AV, Von Gontard A: Management of nocturnal enuresis. preterm birth after threatened preterm labour. Cochrane Database Syst Rev
BMJ 2013;347:f6259. 2013;(10):CD005938.
Carel JC et al: Consensus statement on the use of gonadotropin-releasing hormone Penson D et al: Effectiveness of hormonal and surgical therapies for cryptorchi-
analogs in children. Pediatrics 2009;123:752. dism: A systematic review. Pediatrics 2013;131:e1897.
Carel JC et al: Long-term mortality after recombinant growth hormone treat- Richmond E, Rogol AD: Current indications for growth hormone therapy for
ment for isolated growth hormone deficiency or childhood short stature: children and adolescents. Endocr Dev 2010;18:92.
Preliminary report of the French SAGhE study. J Clin Endocrinol Metab Rosenfeld RG, Hwa V: The growth hormone cascade and its role in mammalian
2012;97:416. growth. Horm Res 2009;71(Suppl 2):36.
Collett-Solberg PF et al: The role of recombinant human insulin-like growth Sävendahl L et al: Long-term mortality and causes of death in isolated GHD,
factor-I in treating children with short stature. J Clin Endocrinol Metab ISS, and SGA patients treated with recombinant growth hormone during
2008;93:10. childhood in Belgium, The Netherlands, and Sweden: Preliminary report of
Dong Q, Rosenthal SM: Endocrine disorders of the hypothalamus and pituitary. 3 countries participating in the EU SAGhE study. J Clin Endocrinol Metab
In: Swaiman KF, Ashwal S, Ferriero DM (editors): Pediatric Neurology, 2012;97:E213.
5th ed. Mosby, Inc. (Elsevier, Inc.), 2011. Snyder PJ: Treatment of hyperprolactinemia due to lactotroph adenoma and other
Dreicer R et al: New data, new paradigms for treating prostate cancer patients— causes. Available online at: www.uptodate.com.
VI: Novel hormonal therapy approaches. Urology 2011;78(5 Suppl):S494. Speroff L, Fritz MA: Clinical Gynecologic Endocrinology and Infertility, 8th ed.
Gabe SG et al: Obstetrics: Normal and Problem Pregnancies, 6th ed. Churchill Lippincott Williams & Wilkins, 2010.
Livingstone, 2012. Strauss JF, Barbieri RL: Yen & Jaffe’s Reproductive Endocrinology, 6th ed. Elsevier,
Han TS, Bouloux PM: What is the optimal therapy for young males with hypogo- 2009.
nadotropic hypogonadism? Clin Endocrinol 2010;72:731. Surrey ES: Gonadotropin-releasing hormone agonist and add-back therapy: What
Hodson EM, Willis NS, Craig JC: Growth hormone for children with chronic do the data show? Curr Opin Obstet Gynecol 2010;22:283.
kidney disease. Cochrane Database Syst Rev 2012;(2):CD003264.